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Molecular Basis of Coupling Between the DIII Voltage-Sensor and Pore of
a Sodium Channel
Manoel Arcisio-Miranda, Yukiko Muroi, Sandipan Chowdhury,
Baron Chanda.
University of Wisconsin, Madison, WI, USA.
The activation of voltage-sensors, upon depolarization, leads to the opening of
pore gates in a voltage-dependent sodium channel. To elucidate the molecular
principles underlying this conformational coupling, we have investigated a pu-
tative gating interface in domain III of the sodium channel using voltage-clamp
fluorimetry and tryptophan-scanning mutagenesis. Most mutations have similar
energetic effects on voltage-sensor activation and pore opening. However, sev-
eral mutants stabilized the activated voltage-sensor while concurrently destabi-
lizing the open pore. When these mutants were mapped onto a homology model
of the sodium channel, most of them were localized to hinge regions of the gat-
ing interface. Our analysis shows that these residues are involved in energetic
coupling of the voltage-sensor and the pore when both are in the resting or
activated conformation. These results support the notion that electromechanical
coupling in a voltage-dependent ion channel involves movement of rigid
helical segments connected by elastic hinges.
Support: National Institutes of Health, AHA and Shaw Scientific Award.
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The Biophysical Costs Associated With Tetrodotoxin Resistance in the
Garter Snake, Thamnophis Sirtalis
Chong Hyun Lee1, David K. Jones1, Christopher Ahern2, Maen F. Sarhan2,
Peter C. Ruben1.
1Simon Fraser University, Burnaby, BC, Canada, 2University of British
Columbia, Vancouver, BC, Canada.
Tetrodotoxin (TTX) is a potent toxin that specifically binds to voltage gated
sodium channels (NaV). TTX binding physically blocks the flow of sodium
ions through NaV, thereby preventing action potential generation and propa-
gation. Populations of the garter snake, Thamnophis sirtalis, have evolved
TTX resistance by substituting amino acid residues in the highly conversed
domain IV P-loop of NaV1.4, allowing them to feed on tetrodotoxic newts.
Different populations of the garter snake have different degrees of TTX-resis-
tance closely related to the number of amino acid substitutions. Here, we
tested the voltage dependence, kinetics, and ion selectivity of NaV1.4 con-
taining sequences from different garter snake populations. Using Xenopus
oocytes under cut-open voltage clamp, we observed significant changes in
voltage dependent gating properties of the TTX resistant NaV. The most
TTX-resistant channel had hyperpolarized activation midpoint (6 mV) com-
pared to TTX-sensitive channels. Fast inactivation of the TTX-resistant NaV
had significant depolarizing shifts of 2.2 mV in mildly TTX-resistant chan-
nels, and 4.5 mV in strongly TTX-resistant channels. Depolarizing shifts in
slow inactivation were also observed in TTX-resistant channels with 20 mV
and 16 mV shifts in mildly resistant and strongly resistant channels, respec-
tively. In addition, ion selectivity and permeability of TTX-resistant channels
were significantly different from those of the TTX-sensitive channel. These
results suggest TTX resistance comes at a cost to channel performance caused
by changes in the gating properties and ion selectivity of TTX-resistant
sodium channels.
Supported by a NSERC Discovery Grant to PCR.
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A Cation-Pi Interaction in the Cardiac Sodium Channel Local Anesthetic
Receptor Discriminates Between Antiarrythmics
Stephan A. Pless, Jason D. Galpin, Adam Frankel, Christopher A. Ahern.
University of British Columbia, Vancouver, BC, Canada.
Voltage-gated sodium channels generate the upstroke of the cardiac action po-
tential. Anti-arrhythmic and local anesthetic compounds inhibit these channels
and are widely employed to modulate cellular excitability. Previous studies
have shown that two conserved aromatic residues in DIVS6 are crucial for
binding of antiarrythmics as their mutation to non-aromatic side-chains reduces
drug affinity. Furthermore, it has been shown that in the skeletal sodium chan-
nel isoform, the aromatic residue Phe1579, but not Tyr1586, forms a cation-pi
interaction with lidocaine or QX-314. However, it remains unclear if this
cation-pi interaction is conserved in the cardiac sodium channel isoform and
if it is a general trait of anti-arrhythmic drugs. In this study we employ in vivo
nonsense suppression to incorporate a series of fluorinated phenylalanine
derivatives at two homologous positions in the cardiac sodium channel
Nav1.5, Phe1760 and Tyr1767, to determine if the functionally and structur-
ally related compounds lidocaine, mexiletine, flecainide and ranolazine bind
to Nav1.5 via a cation-pi interaction. Our results show that Phe1760 forms a
cation-pi interaction with lidocaine and mexiletine, but not flecainide orranolazine. Furthermore, none of the compounds tested formed a cation-pi
interaction with Tyr1767. These findings present a significant step towards de-
ciphering the subtle differences that determine the binding modes of function-
ally and structurally related anti-arrhythmic compounds to cardiac sodium
channels.
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Use-Dependent Block of Nav1.4 Human Paramyotonia Congenita Muta-
tion By Ranolazine
Nesrine El-Bizri1, John C. Shryock1, Alfred L. George2, Luiz Belardinelli1,
Sridharan Rajamani1.
1Gilead Sciences, Palo Alto, CA, USA, 2Vanderbilt University School of
Medicine, Nashville, TN, USA.
Ranolazine, an anti-anginal drug, has been shown to bind to inactivated
state(s) of the cardiac (Nav1.5) and peripheral neuron (Nav1.7 and Nav1.8)
Naþ channels and cause use-dependent block (UDB).The drug also reduces
persistent (late) current caused by Nav1.5 gain-of-function Naþ channel mu-
tations. We tested the hypothesis that ranolazine would have similar effects on
the skeletal muscle wild-type (WT) Naþ channel, Nav1.4, and on the para-
myotonia congenita gain-of-function mutation, R1448C, which is associated
with sustained firing of action potentials and long-lasting involuntary con-
tractions leading to muscle stiffness. Whole-cell INa was recorded from
HEK293 cells transiently expressing the human Nav1.4 WT and R1448C
channels. At a holding potential of 140 mV, ranolazine (3-100 mM) caused
UDB (10 and 30 Hz) of WT and R1448C INa with half-maximal inhibitory
concentrations (IC50) of 63.954.8 (n=3-5 cells) and 20.352.1 mM (n=4 cells)
for WT and 63.755.4 (n=3-5 cells) and 20.952.4 mM (n=3-7 cells) for
R1448C, respectively. UDB (10 Hz) of R1448C INa increased when the
holding potential was changed from 140 to 90 mV (IC50= 10.851.7 mM,
n=5-6 cells). Ranolazine (10-100 mM) caused a concentration-dependent
hyperpolarizing shift in the voltage-dependence of intermediate and slow in-
activation of WT (n=3-7 cells) and R1448C (n=3-7 cells) INa. Ranolazine
(30 mM) slowed the recovery from inactivation of both WT (n=3 cells) and
R1448C channels (n=5 cells). An increase of depolarizing pulse duration
from 2 to 20 msec did not affect the UDB of WT (n=4 cells) or R1448C
(n=4-5 cells) INaby 30 mM ranolazine. The data suggest that ranolazine blocks
the open state and interacts with the inactivated states of Nav1.4 WT and
R1448C channels. The state and UDB of Nav1.4 channels by ranolazine
may be useful to inhibit sustained action potential firing, as seen in paramyo-
tonia congenita.
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Cardiac Dynamics In-Silico: Pharmacological Targeting of Long QT3
Syndrome
Jonathan D. Moreno1, John R. Bankston2, Robert S. Kass2,
Colleen E. Clancy3.
1Weill Cornell Medical College, New York, NY, USA, 2Columbia
University, New York, NY, USA, 3University of California, Davis, Davis,
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The treatment of cardiac arrhythmia is largely empirical due to incomplete
understanding of antiarrhythmic drug-receptor dynamics. However, our labo-
ratory has recently determined that drug receptor interactions of commonly
prescribed local anesthetics (LAs) can be described using theoretical models
based on a limited number of experimentally determined parameters. Here,
we use experimental function data from cardiac Naþ channels harboring dis-
ease-linked mutations to build models that simulate measured properties of
drug interactions with mutant channels. We developed computational models
of 3 closely linked LQT3 mutants: deltaKPQ, D1790G, and Y1795C that ac-
count for 1) mutant-specific biophysical channel gating characteristics includ-
ing mean open time and persistent Naþ current; 2) drug partitioning that
underlies situation-dependent blockade; and 3) drug sensitivity to LAs that
matches experimental data for steady-state inactivation (SSI), tonic block
(TB), concentration and frequency dependence of use-dependent block
(UDB), and recovery from UDB. Experimental 30yM flecainide block of
D1790G induces a 5.5 5 1.4mV hyperpolarizing shift in SSI, similar to our
simulations (6.25mV). Experimental fits to TB reveal an IC50 of 48yM
(simulations: 53.5yM), and for UDB, an IC50 of 1.7yM (simulations: 2yM).
Frequency dependence of UDB is in excellent agreement with experimental
data over a broad range of pacing frequencies (1 - 10Hz). We have built
similarly predictive models of LA interactions for deltaKPQ and Y1795C.
The in-silico platform that we have developed to predict drug-receptor inter-
actions can be used to predict how subtle alterations to gating resulting from
the mutations, as well as differential sensitivities to LAs, predispose patients
to under- or overly-effective therapy with commonly prescribed antiarrhyth-
mic drugs.
